PROLYMPHOCYTIC LEUKEMIA
Clinical trials for PROLYMPHOCYTIC LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new PROLYMPHOCYTIC LEUKEMIA trials appear
Sign up with your email to follow new studies for PROLYMPHOCYTIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Half-Matched donor transplant offers hope for blood cancer patients
Disease control CompletedThis study tested a less intense stem cell transplant for people with various blood cancers who are older or have other health issues. It used a half-matched family donor (like a parent or sibling) and a milder chemo and radiation preparation. The goal was to see how many patient…
Matched conditions: PROLYMPHOCYTIC LEUKEMIA
Phase: PHASE2 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated May 26, 2026 05:51 UTC
-
New drug combo may reduce deadly transplant complication in blood cancer patients
Disease control CompletedThis study looked at 174 adults with blood cancers who received a stem cell transplant from an unrelated donor. Researchers compared different combinations of immune-suppressing drugs to find the best way to prevent graft-versus-host disease (GVHD), a serious complication where d…
Matched conditions: PROLYMPHOCYTIC LEUKEMIA
Phase: PHASE3 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated May 26, 2026 05:48 UTC
-
Promising combo tackles tough blood cancers
Disease control CompletedThis early-phase study tested a combination of two drugs, acalabrutinib and obinutuzumab, in 69 people with chronic lymphocytic leukemia (CLL) or related blood cancers. The goal was to see if the combination was safe and could shrink or eliminate cancer. Participants included tho…
Matched conditions: PROLYMPHOCYTIC LEUKEMIA
Phase: PHASE1 • Sponsor: Acerta Pharma BV • Aim: Disease control
Last updated May 22, 2026 13:50 UTC
-
New combo therapy shows promise for Hard-to-Treat blood cancers
Disease control CompletedThis study tested a combination of two drugs, MOR00208 and lenalidomide, in 41 people with chronic lymphocytic leukemia (CLL) or related blood cancers. The goal was to see if the combination could shrink or control the cancer in patients who had not responded to prior treatments …
Matched conditions: PROLYMPHOCYTIC LEUKEMIA
Phase: PHASE2 • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Disease control
Last updated May 14, 2026 12:04 UTC